Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva生物製品股份下跌，該公司宣佈FDA授予VCN-01用於視網膜母細胞瘤治療的罕見兒科藥物認定。
Theriva Biologics Shares Are Trading Lower. The Company Announced That the FDA Granted Rare Pediatric Drug Designation for VCN-01 for the Treatment of Retinoblastoma.
Theriva生物製品股份下跌，該公司宣佈FDA授予VCN-01用於視網膜母細胞瘤治療的罕見兒科藥物認定。
資訊熱榜
更新時間